A therapy using a patient's own proximal basal stem cells shows promise to treat idiopathic pulmonary fibrosis.

Columnist Ann Reynoso says she's struggling to lose weight, but each step forward, no matter how small, is still progress.

Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating bexotegrast as an IPF treatment.

While every person's journey with PF is unique, columnist Sam Kirton stresses the importance of support groups for patients and caregivers.

It was five years ago this month that COVID-19 was beginning to consume the headlines. Around the world, those headlines provided an early view of what a pandemic might look like here in the U.S. In ...

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

Columnist Sam Kirton and his wife go with the flow when changes are necessary, such as rescheduling a Halloween party to the advent of spring.

Enrollment is now complete in a Phase 2b clinical trial, dubbed CORAL, that’s testing nalbuphine extended-release (ER) tablets — planned to be marketed as Haduvio — in people with idiopathic pulmonary ...